Arosio M - Search Results

1

Elevated circulating somatostatin levels in acromegaly.

Arosio M, Porretti S, Epaminonda P, Giavoli C, Gebbia C, Penati C, Beck-Peccoz P, Peracchi M. Arosio M, et al. J Endocrinol Invest. 2003 Jun;26(6):499-502. doi: 10.1007/BF03345210. J Endocrinol Invest. 2003. PMID: 12952361 Free article.

2

Ectopic acromegaly.

Faglia G, Arosio M, Bazzoni N. Faglia G, et al. Among authors: arosio m. Endocrinol Metab Clin North Am. 1992 Sep;21(3):575-95. Endocrinol Metab Clin North Am. 1992. PMID: 1521513 Review.

3

Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.

Arosio M, Nissim M, Ballabio M, Orefice R, Bazzoni N, Faglia G. Arosio M, et al. Acta Endocrinol (Copenh). 1991 Aug;125(2):150-9. doi: 10.1530/acta.0.1250150. Acta Endocrinol (Copenh). 1991. PMID: 1897332

4

Acromegaly and thymic hyperplasia: a case report.

Bazzoni N, Ambrosi B, Arosio M, Barbareschi M, Losa M, Faglia G. Bazzoni N, et al. Among authors: arosio m. J Endocrinol Invest. 1990 Dec;13(11):931-5. doi: 10.1007/BF03349660. J Endocrinol Invest. 1990. PMID: 2090673

5

[Treatment of acromegaly with octreotide, a synthetic analog of somatostatin with extended action].

Arosio M, Bazzoni N, Faglia G. Arosio M, et al. Minerva Endocrinol. 1990 Jan-Mar;15(1):29-36. Minerva Endocrinol. 1990. PMID: 2274011 Review. Italian.

6

Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell.

Beck-Peccoz P, Bassetti M, Spada A, Medri G, Arosio M, Giannattasio G, Faglia G. Beck-Peccoz P, et al. Among authors: arosio m. J Clin Endocrinol Metab. 1985 Sep;61(3):541-6. doi: 10.1210/jcem-61-3-541. J Clin Endocrinol Metab. 1985. PMID: 2410443

7

Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.

Arosio M, Ambrosi B, Guglielmino L, Faglia G. Arosio M, et al. J Endocrinol Invest. 1985 Oct;8(5):449-53. doi: 10.1007/BF03348536. J Endocrinol Invest. 1985. PMID: 2867112

8

Circulating levels of growth hormone, insulin-like growth factor-I and prolactin in normal, growth retarded and anencephalic human fetuses.

Arosio M, Cortelazzi D, Persani L, Palmieri E, Casati G, Baggiani AM, Gambino G, Beck-Peccoz P. Arosio M, et al. J Endocrinol Invest. 1995 May;18(5):346-53. doi: 10.1007/BF03347836. J Endocrinol Invest. 1995. PMID: 7594222 Clinical Trial.

9

Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients.

Muratori M, Arosio M, Gambino G, Romano C, Biella O, Faglia G. Muratori M, et al. Among authors: arosio m. J Endocrinol Invest. 1997 Oct;20(9):537-46. doi: 10.1007/BF03348016. J Endocrinol Invest. 1997. PMID: 9413808 Clinical Trial.

10

Lack of effect of hexarelin on TRH-induced TSH response in normal adult man.

Arosio M, Casati G, Biella O, Porretti S, Imbimbo BP, Faglia G. Arosio M, et al. J Endocrinol Invest. 1998 Apr;21(4):239-44. doi: 10.1007/BF03347309. J Endocrinol Invest. 1998. PMID: 9624598 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters